Answers are grounded in this paper and cite their sources.
Alopecia areata (AA) is a non-scarring, immune-mediated hair-loss disorder associated with disrupted hair-follicle immune privilege, inflammation, and oxidative imbalance. This study evaluated physiological, immune, and oxidative biomarkers and their relationships with severity. This case-control study included 40 patients with AA and 40 healthy controls. Serum zonulin, CXCL10, tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), and reduced glutathione (GSH) were measured. Disease severity was scored using the Severity of Alopecia Tool (SALT). Analyses included independent-samples t-tests, Hedges’ g, Spearman correlations with false-discovery-rate (FDR) correction, receiver operating characteristic (ROC) analysis, and reduced multivariable linear regression. Age and sex did not differ significantly between groups. Compared with controls, patients with AA had higher zonulin, CXCL10, TNF-α, and MDA, and lower GSH (all P < 0.001). The largest standardized differences were for TNF-α (Hedges’ g = 2.32), MDA (g = 1.75), and GSH (g = −1.38). SALT correlated positively with zonulin (rₛ = 0.859), CXCL10 (rₛ = 0.857), TNF-α (rₛ = 0.842), and MDA (rₛ = 0.848), and negatively with GSH (rₛ = −0.899); all remained significant after FDR correction. A reduced model including TNF-α, MDA, and GSH explained 88.8% of SALT variance (R² = 0.888). TNF-α had the highest discrimination (AUC = 0.966). AA showed a coordinated inflammatory and oxidative-stress profile that tracked severity. TNF-α, MDA, and GSH were informative in the reduced model, whereas zonulin and CXCL10 may reflect broader physiological and immune involvement. These findings support integrated biomarker models; external validation is needed before clinical cut-offs are used.
No takes yet. Share an insight, caveat, or question.
Saif Salah Abdul Hassan (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: